Sign In
Buy SLS
$11.81
+0.590 (+5.26%)
At Close: Aug 04, 2026
All You Need to Know About SELLAS Life Sciences Group, Inc. (SLS) Rating Upgrade to Buy
01:00pm, Thursday, 26'th Mar 2026
SELLAS Life Sciences Group, Inc. (SLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near ter
Wall Street Analysts Believe SELLAS Life Sciences Group, Inc. (SLS) Could Rally 63.58%: Here's is How to Trade
10:56am, Thursday, 26'th Mar 2026
The consensus price target hints at a 63.6% upside potential for SELLAS Life Sciences Group, Inc. (SLS). While empirical research shows that this sought-after metric is hardly effective, an upward tre
SELLAS Life Sciences Group (NASDAQ:SLS) Shares Gap Up on Earnings Beat
01:14am, Saturday, 21'st Mar 2026
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS - Get Free Report) shares gapped up before the market opened on Friday following a better than expected earnings announcement. The stock had previously cl
SELLAS Stock Up 346% in a Year as Cancer Vaccine Trial Nears Its Final 8 Deaths
08:00am, Friday, 20'th Mar 2026
A late-stage clinical biopharmaceutical company focused on immunotherapy for various cancers, SELLAS Life Sciences Group ( NASDAQ:SLS ) is at a genuinely unusual inflection point.
SELLAS Life Sciences Group (NASDAQ:SLS) & Dianthus Therapeutics (NASDAQ:DNTH) Critical Survey
01:32am, Friday, 20'th Mar 2026
SELLAS Life Sciences Group (NASDAQ: SLS - Get Free Report) and Dianthus Therapeutics (NASDAQ: DNTH - Get Free Report) are both medical companies, but which is the better business? We will contrast the
SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update
04:05pm, Thursday, 19'th Mar 2026
– Continued Advancement of Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) - Final Analysis upon Reaching 80 Events –
SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference
04:30pm, Tuesday, 17'th Mar 2026
- Preclinical data show that SLS009 lowers the apoptotic threshold in AML cells by suppressing critical survival pathways - - Preclinical data show that SLS009 lowers the apoptotic threshold in AML ce
SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009
08:35am, Thursday, 12'th Mar 2026
- Study to Enroll 80 Patients Unlikely to Benefit from Venetoclax/Azacitide (Aza/Ven) Therapy in the US and Europe - - SELLAS' Predictive Biomarker and AI Assisted Precision Medicine Models to be Util
What's Going With SELLAS Life Sciences Stock On Wednesday?
12:59pm, Wednesday, 04'th Mar 2026
SELLAS Life Sciences Group Inc. (NASDAQ: SLS) has surged over 200% over the last six months, with a year-to-date stock jump of around 45%.
SELLAS Life Sciences Group Sees Unusually Large Options Volume (NASDAQ:SLS)
01:12am, Tuesday, 24'th Feb 2026
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS - Get Free Report) saw some unusual options trading activity on Monday. Investors purchased 42,324 call options on the stock. This is an increase of appro
Solaris Resources (TSE:SLS) Reaches New 52-Week High – Should You Buy?
05:08am, Sunday, 25'th Jan 2026
Solaris Resources Inc. (TSE: SLS - Get Free Report)'s share price reached a new 52-week high during trading on Friday. The stock traded as high as C$13.12 and last traded at C$12.97, with a volume of
SELLAS Life Sciences Enters Agreement with IMPACT-AML to Expand SLS009 Clinical Program into Europe
08:30am, Wednesday, 14'th Jan 2026
NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS'' or the “Company”), a late-stage clinical biopharmaceutical company focused on the developmen
SELLAS Life Sciences Group Sees Unusually Large Options Volume (NASDAQ:SLS)
02:34am, Saturday, 03'rd Jan 2026
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS - Get Free Report) saw unusually large options trading on Friday. Traders bought 149,934 call options on the company. This is an increase of approximately
SELLAS Life Sciences Group (NASDAQ:SLS) Shares Gap Up – What’s Next?
03:16am, Friday, 02'nd Jan 2026
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS - Get Free Report)'s share price gapped up before the market opened on Wednesday. The stock had previously closed at $3.31, but opened at $3.46. SELLAS Li
SELLAS Life Sciences Stock Is Surging Higher: What's Going On?
03:40pm, Monday, 29'th Dec 2025
SELLAS Life Sciences Group climbs higher after a premarket drop, reversing course as investors seem to react to new trial‑related updates.
